Heat therapy for lung tumors: a new option for inoperable patients?

NCT ID NCT00280189

Terminated Disease control Sponsor: University of Pittsburgh Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at using radiofrequency ablation (RFA) — a procedure that uses heat to destroy tumors — to treat lung cancer or tumors that have spread to the lungs. It is for patients who cannot have surgery due to other health issues. The goal is to see if RFA can control tumors, improve survival, and maintain quality of life. The trial is currently suspended and aims to enroll 72 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiofrequency ablation
What this could lead to: If successful, this could offer a less invasive option to control lung tumors and improve quality of life for patients who cannot undergo surgery.
What could go wrong: This trial is suspended and small (72 participants). It is early-stage research, so results may not be conclusive or widely applicable. Risks include procedure-related complications like pain or chest tube drainage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NSCLC PULMONARY METASTASES

Contacts and locations

Locations

Hillman Cancer Center

Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.